Successes and failures: Do targeted therapies live up to their promise?

ESMO teamed up with the European Association for Cancer Research (EACR) for a joint symposium to explore recent progress in the development of targeted therapies in oncology. The session provided a brief snapshot of just a few novel results in this exciting landscape. Read more here.